Methodologies used to estimate tobacco-attributable mortality: a review.

BMC Public Health
Mónica Pérez-Ríos, Agustín Montes

Abstract

One of the most important measures for ascertaining the impact of tobacco on a population is the estimation of the mortality attributable to its use. To measure this, a number of indirect methods of quantification are available, yet there is no consensus as to which furnishes the best information. This study sought to provide a critical overview of the different methods of attribution of mortality due to tobacco consumption. A search was made in the Medline database until March 2005 in order to obtain papers that addressed the methodology employed for attributing mortality to tobacco use. Of the total of 7 methods obtained, the most widely used were the prevalence methods, followed by the approach proposed by Peto et al, with the remainder being used in a minority of studies. Different methodologies are used to estimate tobacco attributable mortality, but their methodological foundations are quite similar in all. Mainly, they are based on the calculation of proportional attributable fractions. All methods show limitations of one type or another, sometimes common to all methods and sometimes specific.

References

Apr 1, 1979·American Journal of Epidemiology·B L OuelletJ M Lance
Jun 13, 1992·Lancet·J N Rao
Jul 11, 1992·Lancet·J R Ashford
Sep 12, 1992·Lancet·T D SterlingJ J Weinkam
Nov 14, 1992·Lancet·P Skrabanek
Jun 1, 1990·Journal of Community Health·R D GorskyD Dennis
Nov 1, 1988·Preventive Medicine·R D GorskyD Dennis
Apr 1, 1988·Disease-a-month : DM·R J Elin
Jan 1, 1988·Statistics in Medicine·A S Whittemore
Mar 1, 1981·The British Journal of Radiology·P G Smith, R Doll
Jan 1, 1994·Asia-Pacific Journal of Public Health·C P WenD D Yen
Oct 8, 1994·BMJ : British Medical Journal·R DollI Sutherland
Oct 8, 1994·BMJ : British Medical Journal·R Peto
Jul 6, 1994·Journal of the National Cancer Institute·K C ChuL A Ries
Nov 1, 1993·Epidemiology·D L Davis
Jul 15, 1993·American Journal of Epidemiology·T D SterlingJ J Weinkam
Aug 1, 1996·European Journal of Epidemiology·D RothenbacherT M Fliedner
Aug 1, 1996·Regulatory Toxicology and Pharmacology : RTP·P N Lee
Nov 18, 1997·JAMA : the Journal of the American Medical Association·T H LamB Q Liang
May 16, 1998·American Journal of Public Health·B RockhillC Weinberg
Nov 20, 1998·BMJ : British Medical Journal·S R NiuR Peto
Jan 23, 1999·American Journal of Obstetrics and Gynecology·P J SchwinglC M Visness
Feb 10, 1999·São Paulo Medical Journal = Revista Paulista De Medicina·A N Atallah
Mar 17, 1999·American Journal of Public Health·E SingleX Xi
Jul 9, 1999·Journal of Epidemiology and Community Health·H Brønnum-Hansen
Apr 25, 2000·Alcoholism, Clinical and Experimental Research·K MakimotoS Higuchi
Jun 30, 2000·Epidemiology·H Brønnum-Hansen, K Juel
Aug 6, 2000·JAMA : the Journal of the American Medical Association·M J ThunS J Henley
Aug 11, 2000·American Journal of Public Health·D T LevyA Hyland
Sep 21, 2000·American Journal of Epidemiology·A M MalarcherG A Giovino
Nov 7, 2000·JAMA : the Journal of the American Medical Association·R A Levy
Mar 23, 2001·Atencion primaria·E F Santos ZarzaM C Sáenz González
Apr 18, 2001·American Journal of Preventive Medicine·R P HarrisUNKNOWN Methods Work Group, Third US Preventive Services Task Force
May 3, 2001·Gaceta sanitaria·J LlorcaM Delgado-Rodrígueza
Aug 18, 2001·BMJ : British Medical Journal·T H LamR Peto
Aug 23, 2001·Journal of Occupational and Environmental Medicine·M M Nurminen, M S Jaakkola
Aug 1, 1992·Human Gene Therapy·UNKNOWN U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee

❮ Previous
Next ❯

Citations

Mar 8, 2011·Epidemiology·Brian Rostron
Mar 23, 2011·Preventive Medicine·Silvano GallusCarlo La Vecchia
Jan 11, 2011·Medicina clínica·Mónica Pérez-RíosXurxo Hervada-Vidal
Oct 29, 2010·Medicina clínica·José R BanegasCarlos Jiménez-Ruiz
Oct 29, 2010·Medicina clínica·Mónica Pérez-Ríos
Dec 17, 2014·European Journal of Public Health·Marc Luy, Christian Wegner-Siegmundt
Jun 26, 2014·Addiction·Magdalena M MuszyńskaFanny Janssen
Nov 15, 2014·European Journal of Public Health·Henrik Brønnum-Hansen, Bernard Jeune
Aug 16, 2014·Archives of public health = Archives belges de santé publique·Nabil TachfoutiChakib Nejjari
Apr 6, 2017·European Journal of Public Health·Vaida LiutkuteNijole Goštautaite Midttun
Jan 17, 2020·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Fanny Janssen
Sep 11, 2019·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Fanny Janssen
Apr 27, 2013·Tobacco Control·Jose M Martínez-SánchezEsteve Fernández
Nov 27, 2019·Tobacco Induced Diseases·Olfa SaidiRadhouane Fakhfakh
Dec 18, 2020·Revista brasileira de epidemiologia = Brazilian journal of epidemiology·Alexandra Giraldo-OsorioMónica Pérez-Rios
Aug 4, 2009·The Medical Journal of Australia·Freddy SitasAlan D Lopez
Mar 2, 2021·Archivos de bronconeumología·Mónica Pérez-RíosMaría José López
Mar 10, 2021·Revista Española De Cardiología·Julia ReyAlberto Ruano-Ravina
Apr 9, 2021·Journal of Global Health·Alexandra Giraldo-OsorioAlberto Ruano-Ravina
May 31, 2021·Archivos de bronconeumología·Mónica Pérez-RíosMaría José López

❮ Previous
Next ❯

Software Mentioned

SAMMEC ( - Attributable Mortality , Morbidity , and Economic C...
SAMMEC

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.